Skip to main content
Signal8

Evans John M.

SEC insider (Form 3/4/5 filer). CIK 0001786304. CEO at Beam Therapeutics Inc. (BEAM). 36 reported Form 4/5 transactions since Sep 2024; latest on Oct 16, 2026. Located in CAMBRIDGE, MA.

Companies Evans John M. has filed insider reports for

  • Beam Therapeutics Inc. (BEAM): Director, Officer, CEO
Evans John M. profile photo

Evans John M.

CIK: 0001786304

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)19 (52.8%)

Position reduction

Option Exercises (M)13 (36.1%)

Derivative conversions

Awards (A)4 (11.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Beam Therapeutics Inc. logo
BEAM

Beam Therapeutics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (36 total)

  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Oct 16, 2026
    Sale
    Direct
    25K shares at avg. $23.98$600K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Oct 16, 2026
    Exercise
    Direct
    25K shares at avg. $1.03$26K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Oct 15, 2026
    Sale
    Direct
    25K shares at avg. $23.57$589K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Oct 15, 2026
    Exercise
    Direct
    25K shares at avg. $1.03$26K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jun 30, 2026
    Exercise
    Direct
    25K shares at avg. $1.03$26K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jun 30, 2026
    Sale
    Direct
    1.9K shares at avg. $34.84$66K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jun 30, 2026
    Sale
    Direct
    23.1K shares at avg. $34.26$791K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jun 29, 2026
    Exercise
    Direct
    18.7K shares at avg. $0.67$13K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jun 29, 2026
    Sale
    Direct
    13.4K shares at avg. $35.13$472K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jun 29, 2026
    Exercise
    Direct
    6.3K shares at avg. $1.03$7K

1-10 of 36